Deals In Depth: December 2016
Executive Summary
Incyte and Merus signed a broad bispecific antibody collaboration worth $3 million. Lonza acquired contract development and manufacturing organization Capsugel for $5.5 billion. Biopharma companies raised $2.5 billion in December, while funding for device firms was down to just $103 million.